New report highlights WMAHSN impact in first five years


Posted on 22 August 2018 (Permalink)

West Midlands Academic Health Science Network (WMAHSN) has worked to support 3,000 companies and supported projects that benefitted nearly 70,000 people in its first five years, a new report has stated.

The WMAHSN was set up in 2013 to ‘catalyse’ innovation in healthcare; by driving cooperation between the NHS, industry and academia and accelerating adoption of innovation it aims to improve health and generate economic growth.

The report, The First Five Years; Impact Report 2013 – 18 details the impacts the organisation has made on the health and wealth of the region including:

  • 3,000 companies have been supported by WMAHSN;
  • 68,909 people have benefitted from intervention or screening activity as a result of projects conducted by or with WMASHSN involvement;
  • 19,609 NHS staff have been trained through WMAHSN ;
  • 770 sites across the West Midlands have implemented or spread WMAHSN innovations.

Earlier this year, NHS England formally approved a new five year licence for England’s 15 AHSNs, with an option to roll this on for a further five years to 2028.

WMAHSN Managing Director Dr Christopher Parker explained: “Good health leads to good economic growth. Across our network we have built a mutually supportive environment in which all elements of the technology rich West Midlands’ life sciences community are integrated.

“The healthcare economy landscape may have changed markedly since we started our journey but we have built a strong foundation on which we can move forward into our next licence period. Thank you to everyone who has played their part in the success of the WMAHSN.”

WMAHSN The First Five Years; Impact Report 2013 – 18 also includes a selection of case studies – from funding of Genomic Ambassadors to supporting the company behind life-changing, vision-enhancing goggles – as well as information on initiatives to grow enterprise and mentor start-ups.

The report can be viewed and downloaded here.